Adagene

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.

About ADAG

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.

CEO

Pei Zhi Luo

CEOPei Zhi Luo

Employees

138

Employees138

Headquarters

Suzhou, Jiangsu

HeadquartersSuzhou, Jiangsu

Founded

2011

Founded2011

Employees

138

Employees138

ADAG Key Statistics

Market cap

90.45M

Market cap90.45M

Price-Earnings ratio

-2.59

Price-Earnings ratio-2.59

Dividend yield

—

Dividend yield—

Average volume

119.75K

Average volume119.75K

High today

$1.97

High today$1.97

Low today

$1.92

Low today$1.92

Open price

$1.92

Open price$1.92

Volume

8.93K

Volume8.93K

52 Week high

$3.58

52 Week high$3.58

52 Week low

$1.33

52 Week low$1.33

Adagene

Why Robinhood?

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. Show more

ADAG Key Statistics

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.